Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Smith & Nephew Snats ( (SNN) ) has shared an announcement.
On 30 April 2026, Smith & Nephew plc reported that its total issued share capital comprised 877,733,750 ordinary shares of US20¢ each, of which 23,684,605 were held in treasury. As a result, the company’s share capital carrying voting rights consisted of 854,049,145 ordinary shares, each conferring one vote.
The company stated that this voting share figure should be used by investors as the denominator when assessing whether their holdings reach the thresholds that trigger disclosure obligations under UK Financial Conduct Authority transparency rules, clarifying the reference base for future shareholder notifications. The update, released on 1 May 2026, effectively resets the benchmark for reporting significant shareholdings in the company, with implications for institutional investors monitoring regulatory disclosure limits.
The most recent analyst rating on (SNN) stock is a Hold with a $32.00 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.
The score is driven primarily by improving financial performance (margin and cash flow rebound) and supportive technicals (price above major moving averages with positive momentum). Valuation is only average at a 22.7 P/E, while the earnings call adds confidence via upbeat 2026 growth/profit guidance but flags meaningful near-term tariff and reimbursement headwinds.
To see Spark’s full report on SNN stock, click here.
More about Smith & Nephew Snats
Smith & Nephew plc is a UK-based medical technology company that designs and manufactures orthopaedic implants, sports medicine and ear, nose and throat devices, and advanced wound management products. The group serves hospitals and healthcare providers globally, competing in the wider medtech sector with a focus on surgical and wound care solutions for developed and emerging markets.
Average Trading Volume: 912,966
Technical Sentiment Signal: Buy
Current Market Cap: $13.2B
See more insights into SNN stock on TipRanks’ Stock Analysis page.